114 related articles for article (PubMed ID: 30403599)
1. Comparison of the cytotoxic, genotoxic and apoptotic effects of Sugammadex and Neostigmine on human embryonic renal cell (HEK-293).
Büyükfırat E; Koyuncu İ; Karahan MA; Binici O; Altay N; Kirmit A; Gönel A
Cell Mol Biol (Noisy-le-grand); 2018 Oct; 64(13):74-78. PubMed ID: 30403599
[TBL] [Abstract][Full Text] [Related]
2. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
Sacan O; White PF; Tufanogullari B; Klein K
Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
[TBL] [Abstract][Full Text] [Related]
3. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial.
Khuenl-Brady KS; Wattwil M; Vanacker BF; Lora-Tamayo JI; Rietbergen H; Alvarez-Gómez JA
Anesth Analg; 2010 Jan; 110(1):64-73. PubMed ID: 19713265
[TBL] [Abstract][Full Text] [Related]
4. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine.
Jones RK; Caldwell JE; Brull SJ; Soto RG
Anesthesiology; 2008 Nov; 109(5):816-24. PubMed ID: 18946293
[TBL] [Abstract][Full Text] [Related]
5. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
[TBL] [Abstract][Full Text] [Related]
6. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.
Flockton EA; Mastronardi P; Hunter JM; Gomar C; Mirakhur RK; Aguilera L; Giunta FG; Meistelman C; Prins ME
Br J Anaesth; 2008 May; 100(5):622-30. PubMed ID: 18385265
[TBL] [Abstract][Full Text] [Related]
7. Time-dependent effects of sodium arsenite on DNA breakage and apoptosis observed in the comet assay.
Brink A; Schulz B; Kobras K; Lutz WK; Stopper H
Mutat Res; 2006 Feb; 603(2):121-8. PubMed ID: 16384727
[TBL] [Abstract][Full Text] [Related]
8. Sugammadex and neostigmine dose-finding study for reversal of residual neuromuscular block at a train-of-four ratio of 0.2 (SUNDRO20)†,
Kaufhold N; Schaller SJ; Stäuble CG; Baumüller E; Ulm K; Blobner M; Fink H
Br J Anaesth; 2016 Feb; 116(2):233-40. PubMed ID: 26787792
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of sugammadex and neostigmine on postoperative nausea and vomiting.
Yağan Ö; Taş N; Mutlu T; Hancı V
Braz J Anesthesiol; 2017; 67(2):147-152. PubMed ID: 28236862
[TBL] [Abstract][Full Text] [Related]
10. In vitro evaluation of the cytotoxic and genotoxic effects of artemether, an antimalarial drug, in a gastric cancer cell line (PG100).
Alcântara DD; Ribeiro HF; Cardoso PC; Araújo TM; Burbano RR; Guimarães AC; Khayat AS; de Oliveira Bahia M
J Appl Toxicol; 2013 Feb; 33(2):151-6. PubMed ID: 21953315
[TBL] [Abstract][Full Text] [Related]
11. The combination of sugammadex and neostigmine can reduce the dosage of sugammadex during recovery from the moderate neuromuscular blockade.
Cheong SH; Ki S; Lee J; Lee JH; Kim MH; Hur D; Cho K; Lim SH; Lee KM; Kim YJ; Lee W
Korean J Anesthesiol; 2015 Dec; 68(6):547-55. PubMed ID: 26634077
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials.
Carron M; Zarantonello F; Tellaroli P; Ori C
J Clin Anesth; 2016 Dec; 35():1-12. PubMed ID: 27871504
[TBL] [Abstract][Full Text] [Related]
13. Comparison of neostigmine and sugammadex for hemodynamic parameters in cardiac patients undergoing noncardiac surgery.
Kizilay D; Dal D; Saracoglu KT; Eti Z; Gogus FY
J Clin Anesth; 2016 Feb; 28():30-5. PubMed ID: 26796612
[TBL] [Abstract][Full Text] [Related]
14. A comparison of sugammadex and neostigmine for reversal of rocuronium-induced neuromuscular blockade in children.
Ammar AS; Mahmoud KM; Kasemy ZA
Acta Anaesthesiol Scand; 2017 Apr; 61(4):374-380. PubMed ID: 28185260
[TBL] [Abstract][Full Text] [Related]
15. Sugammadex and neostigmine dose-finding study for reversal of shallow residual neuromuscular block.
Schaller SJ; Fink H; Ulm K; Blobner M
Anesthesiology; 2010 Nov; 113(5):1054-60. PubMed ID: 20885293
[TBL] [Abstract][Full Text] [Related]
16. [Sugammadex versus neostigmine in pediatric patients: a prospective randomized study].
Kara T; Ozbagriacik O; Turk HS; Isil CT; Gokuc O; Unsal O; Seyhan E; Oba S
Rev Bras Anestesiol; 2014; 64(6):400-5. PubMed ID: 25437696
[TBL] [Abstract][Full Text] [Related]
17. A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery.
Geldner G; Niskanen M; Laurila P; Mizikov V; Hübler M; Beck G; Rietbergen H; Nicolayenko E
Anaesthesia; 2012 Sep; 67(9):991-8. PubMed ID: 22698066
[TBL] [Abstract][Full Text] [Related]
18. Electromyographic activity of the diaphragm during neostigmine or sugammadex-enhanced recovery after neuromuscular blockade with rocuronium: a randomised controlled study in healthy volunteers.
Schepens T; Cammu G; Saldien V; De Neve N; Jorens PG; Foubert L; Vercauteren M
Eur J Anaesthesiol; 2015 Jan; 32(1):49-57. PubMed ID: 25111539
[TBL] [Abstract][Full Text] [Related]
19. In vivo Comet assay on isolated kidney cells to distinguish genotoxic carcinogens from epigenetic carcinogens or cytotoxic compounds.
Nesslany F; Zennouche N; Simar-Meintières S; Talahari I; Nkili-Mboui EN; Marzin D
Mutat Res; 2007 Jun; 630(1-2):28-41. PubMed ID: 17507283
[TBL] [Abstract][Full Text] [Related]
20. Effect of sugammadex or neostigmine neuromuscular block reversal on bispectral index monitoring of propofol/remifentanil anaesthesia.
Dahaba AA; Bornemann H; Hopfgartner E; Ohran M; Kocher K; Liebmann M; Wilfinger G; Metzler H
Br J Anaesth; 2012 Apr; 108(4):602-6. PubMed ID: 22315331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
